Main Article Content
Assessment of self-monitoring of blood glucose pracce among type 2 diabecs aending General Out-Paent Clinic in a Terary health facility in Osun State, South-west Nigeria
Abstract
Background: Diabetes mellitus (DM) is a chronic non communicable disease that has reached a global pandemic proporon with increasing prevalence, morbidity and mortality, especially in low and middle-income countries. An important component of modern therapy for DM is self-monitoring of blood glucose (SMBG) to inform changes for an improved glycaemic control. However, despite the fact that SMBG is one of the most effecve monitoring and control measures for DM, the prevalence of poor glycaemic control among diabecs in this environment sll calls for concern, hence the impetus for this study. The purpose of this study was to assess the prevalence and paern of SMBG pracce among adult type 2 diabecs aending General Out-Paent Clinic (GOPC) in Osun State University (UNIOSUN) Teaching Hospital, Osogbo, Osun state, Nigeria. This was to determine the frequency, ming and level of SMBG pracce among the parcipants.
Methods: It was a descripve cross-seconal study that used a pre-tested interviewer administered quesonnaire to obtain informaon on the socio-demographic and clinical characteriscs, prevalence and paern of SMBG pracce. One hundred and seventy five adult type 2 diabecs who aended the GOPC between November 2019 and January 2020 who met the inclusion criteria were recruited. The data was analyzed using Stascal Package for Social Science (SPSS).
Results: A total of 175 parcipants took part in this study and 49.1% of them pracced SMBG. Among the parcipants that pracced SMBG, 56.9% checked their fasng blood glucose on daily basis while others checked it on weekly or monthly basis.
Conclusion: This study revealed that the level of SMBG pracce among the study parcipants was fair with a structured paern of pracce, therefore advocacy on SMBG pracce with emphasis on knowledge of the structured paern of pracce is strongly recommended for improved glycaemic control.



